Systematized linear porokeratosis: Concept of type 2 segmental manifestation implies an increased cancer risk

Journal of Dermatology

Volumn 39, Issue 11, 2012, Pages 953-954

  Schwarz, Nadine ^a   Stadie, Volker ^a   Kreft, Burkhard ^a   Happle, Rudolf ^b   Marsch, Wolfgang Ch ^a   Fiedler, Eckhard ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CETUXIMAB; PACLITAXEL;

ACTINIC POROKERATOSIS; ADULT; BONE METASTASIS; CANCER RISK; CASE REPORT; CHEMORADIOTHERAPY; FEMALE; GENERAL ANESTHESIA; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; INCONTINENTIA PIGMENTI; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; SKIN MANIFESTATION; SKIN TUMOR;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MOSAICISM; POROKERATOSIS; RISK FACTORS; SKIN NEOPLASMS;

EID: 84868201369     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01607.x     Document Type: Letter

References (5)

1. Happle R,. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999; 41: 143-164.
2. Happle R,. Mibelli revisited: a case of type 2 segmental porokeratosis from 1893. J Am Acad Dermatol 2010; 62: 136-138.
3. Poblete-Gutiérrez P, Wiederholt T, König A, et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004; 114: 1467-1474. (Pubitemid 40385577)
4. Happle R,. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology 1997; 195: 20-25. (Pubitemid 27326703)
5. Murata Y, Kumano K, Takai T,. Type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematized pattern of involvement and pronounced cancer proneness. Eur J Dermatol 2001; 11: 191-194. (Pubitemid 32472667)